Top

Published in:

Open Access 01-12-2014 | COMMENTARY

The Brighton declaration: the value of non-communicable disease modelling in population health sciences

Authors: Laura Webber, Oliver T. Mytton, Adam D. M. Briggs, James Woodcock, Peter Scarborough, Klim McPherson, Simon Capewell

Published in: European Journal of Epidemiology | Issue 12/2014

Excerpt

The Brighton declaration arose out of a one day workshop held in Brighton in September 2013 as part of the Society for Social Medicine annual conference. The workshop convened UK based non-communicable disease modellers to discuss the challenges and opportunities for non-communicable disease modelling in the UK. The declaration describes the value and importance of non-communicable disease modelling, both for research and for informing health policy. The declaration also describes challenges and issues for non-communicable disease modelling. The declaration has been endorsed by many non-communicable disease modellers in the UK. …

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al. Global and regional mortality from 235 causes of death for 20 age groups in, 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet. 2012;380:2095–128.PubMedCrossRef

Stout NK, Knudsen AB, Kong CY, McMahon PM, Gazelle GS. Calibration methods used in cancer simulation models and suggested reporting guidelines. Pharmacoeconomics. 2009;27:533–45.PubMedCentralPubMedCrossRef

Astolfi R, Lorenzoni L, Oderkirk J. Informing policy makers about future health spending: a comparative analysis of forecasting methods in OECD countries. Health Policy. 2012;107:1–10.PubMedCrossRef

Barhak J, Isaman DJM, Ye W, Lee D. Chronic disease modeling and simulation software. J Biomed Inform. 2010;43:791–9.PubMedCentralPubMedCrossRef

Kopec JA, Sayre EC, Flanagan WM, Fines P, Cibere J, Rahman MM, Bansback NJ, Anis AH, Jordan JM, Sobolev B, Aghajanian J, Kang W, Greidanus NV, Garbuz DS, Hawker GA, Badley EM. Development of a population-based microsimulation model of osteoarthritis in Canada. Osteoarthr Cartil. 2010;18:303–11.PubMedCrossRef

Unal B, Capewell S, Critchley JA. Coronary heart disease policy models: a systematic review. BMC Public Health. 2006;6:213.PubMedCentralPubMedCrossRef

Maglio PP, Mabry PL. Agent-based models and systems science approaches to public health. Am J Prev Med. 2011;40:392–4.PubMedCentralPubMedCrossRef

World Health Organization. The Ottawa charter for health promotion. Geneva. 1986.

Purshouse RC, Meier PS, Brennan A, Taylor KB, Rafia R. Estimated effect of alcohol pricing policies on health and health economic outcomes in England: an epidemiological model. Lancet. 2010;375:1355–64.PubMedCrossRef

10.

Jarrett J, Woodcock J, Griffiths UK, Chalabi Z, Edwards P, Roberts I, Haines A. Effect of increasing active travel in urban England and wales on costs to the National Health Service. Lancet. 2012;379:2198–205.PubMedCrossRef

11.

Kahlmeier S, Racioppi F, Cavill N, Rutter H, Oja P. “Health in all policies” in practice: guidance and tools to quantifying the health effects of cycling and walking. J Phys Act Health. 2010;7(Suppl 1):S120–5.PubMed

12.

Cobiac LJ, Magnus A, Lim S, Barendregt JJ, Carter R, Vos T. Which interventions offer best value for money in primary prevention of cardiovascular disease? PLoS ONE. 2012;7:e41842.PubMedCentralPubMedCrossRef

13.

McPherson K, Marsh T, Brown M. Foresight. Tackling obesities: future choices—modelling future trends in obesity and the impact on health. 2nd ed. London: Government Office for Science; 2007.

14.

Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108:2205–40.PubMedCentralPubMedCrossRef

15.

Pharoah PDP, Sewell B, Fitzsimmons D, Bennett HS, Pashayan N. Cost effectiveness of the NHS breast screening programme: life table model. BMJ. 2013;346:f2618.PubMedCentralPubMedCrossRef

16.

Woodcock J, Tainio M, Cheshire J, O’Brien O, Goodman A. Health effects of the London bicycle sharing system: health impact modelling study. BMJ. 2014;348:g425.PubMedCentralPubMedCrossRef

17.

Kopec JA, Finès P, Manuel DG, Buckeridge DL, Flanagan WM, Oderkirk J, Abrahamowicz M, Harper S, Sharif B, Okhmatovskaia A, Sayre EC, Rahman MM, Wolfson MC. Validation of population-based disease simulation models: a review of concepts and methods. BMC Public Health. 2010;10:710.PubMedCentralPubMedCrossRef

18.

Weinstein MC, O’Brien B, Hornberger J, Jackson J, Johannesson M, McCabe C, Luce BR. Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR task force on good research practices-modeling studies. Value Health. 2003;6:9–17.PubMedCrossRef

19.

Philips Z, Ginnelly L, Sculpher M, Claxton K, Golder S, Riemsma R, Woolacoot N, Glanville J. Review of guidelines for good practice in decision-analytic modelling in health technology assessment. Health Technol Assess. 2004, 8: iii–iv, ix–xi: 1–158.

20.

Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D, Augustovski F, Briggs AH, Mauskopf J, Loder E. Consolidated health economic evaluation reporting standards (CHEERS) statement. BMJ. 2013;346:f1049.PubMedCrossRef

21.

Caro JJ, Briggs AH, Siebert U, Kuntz KM. Modeling good research practices—overview: a report of the ISPOR-SMDM modeling good research practices task force–1. Value Health. 2012;15:796–803.PubMedCrossRef

Title: The Brighton declaration: the value of non-communicable disease modelling in population health sciences
Authors: Laura Webber
Oliver T. Mytton
Adam D. M. Briggs
James Woodcock
Peter Scarborough
Klim McPherson
Simon Capewell
Publication date: 01-12-2014
Publisher: Springer Netherlands
Published in: European Journal of Epidemiology / Issue 12/2014
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-014-9978-0

ACC 2024 Congress

Springer Medicine

The Brighton declaration: the value of non-communicable disease modelling in population health sciences

Excerpt

ACC 2024 Congress

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2014

A note of thanks

The Consortium on Health and Ageing: Network of Cohorts in Europe and the United States (CHANCES) project—design, population and data harmonization of a large-scale, international study

Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES)

Urinary sodium excretion is associated with short sleep duration

The Generation R Study: Biobank update 2015

Early origins of chronic obstructive lung diseases across the life course